Evaluation of an oral Beta-caryophyllene Indena Phytosome ® for the treatment of pain and inflammation in interstitial cystitis
Clinical Hemorheology and Microcirculation · 2026-03 · 92 (3-4) · 65-76
DOI: 10.1177/13860291261442989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hemorheology and Microcirculation, online erschienen am 24.04.2026. Verfasst von Hannah White und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dalhousie University, Halifax, Canada. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Polycyclic Sesquiterpenes, Inflammation, Sesquiterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Mitacs.
Abstract (Originalsprache)
Background
Interstitial cystitis (IC), a chronic inflammatory condition of the urinary bladder characterized by pain and difficulties with urination, has limited treatment options. Beta-caryophyllene (BCP) is a sesquiterpene with anti-inflammatory and analgesic properties, but has poor water solubility and limited intestinal absorption which may limit oral bioavailability . Indena Phytosome ® is a proprietary food-grade lecithin-based delivery system that optimizes the bioavailability and pharmacokinetic profile of natural phytochemicals like BCP by producing a stable solid dispersion suitable for oral delivery.
Objective
To examine the therapeutic potential of an oral BCP Indena Phytosome® formulation (BCP Indena Phytosome ® ) for the treatment of IC.
Methods
Female BALB/c mice were pre-treated with BCP Indena Phytosome ® or empty Indena Phytosome ® vehicle, then IC was induced using lipopolysaccharide. 24 h later, inflammation was evaluated using intravital microscopy and histology. Pain was evaluated using behavior scoring and von Frey asethesiometry.
Results
Pre-treatment with BCP Indena Phytosome ® reduced leukocyte adhesion, histology scores, and behavior scores in IC mice, indicating a reduction in inflammation and pain. Lipopolysaccharide administration did not alter leukocyte rolling, capillary perfusion, or von Frey scores.
Conclusions
Oral BCP Indena Phytosome ® effectively reduces pain and inflammation in experimental IC by decreasing leukocyte adhesion and extravasation in the bladder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Dalhousie University, Halifax, Canada.
- Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada.
- Department of Physiology and Biophysics, Dalhousie University, Halifax, Canada.
- Department of Urology, Dalhousie University, Halifax, Canada.
- Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Canada.
Förderung
- Mitacs
Zitieren
APA
White, H., Dickson, K., Scott, C., Agonh, D. N., Cox, A., Kelly, M., Zhou, J., & Lehmann, C. (2026). Evaluation of an oral Beta-caryophyllene Indena Phytosome ® for the treatment of pain and inflammation in interstitial cystitis. Clinical Hemorheology and Microcirculation, 92(3-4), 65-76. https://doi.org/10.1177/13860291261442989
Vancouver
White H, Dickson K, Scott C, Agonh DN, Cox A, Kelly M, et al. Evaluation of an oral Beta-caryophyllene Indena Phytosome ® for the treatment of pain and inflammation in interstitial cystitis. Clinical Hemorheology and Microcirculation. 2026;92(3-4):65-76. doi:10.1177/13860291261442989
BibTeX
@article{White2026,
author = {White, Hannah and Dickson, Kayle and Scott, Cassidy and Agonh, Daniel Neira and Cox, Ashley and Kelly, Melanie and Zhou, Juan and Lehmann, Christian},
title = {Evaluation of an oral Beta-caryophyllene Indena Phytosome ® for the treatment of pain and inflammation in interstitial cystitis},
journal = {Clinical Hemorheology and Microcirculation},
year = {2026},
volume = {92},
number = {3-4},
pages = {65--76},
doi = {10.1177/13860291261442989}
}
EUVIMED